AMGN
Amgen Inc.
Stock
$407.27−14.24 (−3.38%)Close Oct 1, 2026
| EBITDA (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $16.1B | +17.4% | 2.3% | 3.0% |
| EBITDA (TTM) | $16.1B |
|---|---|
| YoY | +17.4% |
| 5-year CAGR | 2.3% |
| 10-year CAGR | 3.0% |
EBITDA
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $14.2B | +10.9% |
| 2024 | $12.9B | +7.4% |
| 2023 | $12.0B | −7.8% |
| 2022 | $13.0B | +17.6% |
| 2021 | $11.0B | −13.4% |
| 2020 | $12.7B | +7.2% |
| 2019 | $11.9B | −2.7% |
| 2018 | $12.2B | +2.4% |
| 2017 | $11.9B | +0.2% |
| 2016 | $11.9B | +12.5% |
| 2015 | $10.6B | +27.7% |
| 2014 | $8.3B | +15.8% |
| 2013 | $7.2B | +7.3% |
| 2012 | $6.7B | +24.1% |
| 2011 | $5.4B | −18.1% |
| 2010 | $6.6B | +0.1% |
| 2009 | $6.6B | +4.3% |
| 2008 | $6.3B | +21.3% |
| 2007 | $5.2B | — |